CA3107017A1 - Formes cristallines de tenofovir alafenamide - Google Patents

Formes cristallines de tenofovir alafenamide Download PDF

Info

Publication number
CA3107017A1
CA3107017A1 CA3107017A CA3107017A CA3107017A1 CA 3107017 A1 CA3107017 A1 CA 3107017A1 CA 3107017 A CA3107017 A CA 3107017A CA 3107017 A CA3107017 A CA 3107017A CA 3107017 A1 CA3107017 A1 CA 3107017A1
Authority
CA
Canada
Prior art keywords
crystalline form
tenofovir alafenamide
succinic acid
peaks
taf
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3107017A
Other languages
English (en)
Inventor
Fabio E. S. Souza
Avedis KARADEOLIAN
Alexander J. Stirk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Apotex Inc
Original Assignee
Apotex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Apotex Inc filed Critical Apotex Inc
Priority to CA3107017A priority Critical patent/CA3107017A1/fr
Publication of CA3107017A1 publication Critical patent/CA3107017A1/fr
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • AIDS & HIV (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA3107017A 2021-01-26 2021-01-26 Formes cristallines de tenofovir alafenamide Pending CA3107017A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA3107017A CA3107017A1 (fr) 2021-01-26 2021-01-26 Formes cristallines de tenofovir alafenamide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA3107017A CA3107017A1 (fr) 2021-01-26 2021-01-26 Formes cristallines de tenofovir alafenamide

Publications (1)

Publication Number Publication Date
CA3107017A1 true CA3107017A1 (fr) 2022-07-26

Family

ID=82593832

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3107017A Pending CA3107017A1 (fr) 2021-01-26 2021-01-26 Formes cristallines de tenofovir alafenamide

Country Status (1)

Country Link
CA (1) CA3107017A1 (fr)

Similar Documents

Publication Publication Date Title
US11345706B2 (en) Crystalline forms of Acalabrutinib
US10662178B2 (en) Crystalline form of Olaparib
US11236066B2 (en) Crystalline forms of niraparib tosylate
WO2023087101A1 (fr) Sels de ruxolitinib et leurs formes cristallines
US11667656B2 (en) Crystalline forms of Tenofovir alafenamide
CA3107017A1 (fr) Formes cristallines de tenofovir alafenamide
US10822309B2 (en) Crystalline form of Eluxadoline
US11072620B2 (en) Crystalline forms of Ponatinib hydrochloride
EP3575300A1 (fr) Nouvelles formes cristallines d'ibrutinib
CA3151879A1 (fr) Sel d'acesulfamate de tenofovir alafenamide
US20200317616A1 (en) Crystalline Form of Betrixaban Maleate
US11814356B1 (en) Salt of cabozantinib
US10611772B2 (en) Crystalline form of Ribociclib succinate
US10632107B2 (en) Crystalline forms of benzoquinoline inhibitors of vesicular monoamine transporter 2
US20210292272A1 (en) Salts of Zuclomiphene
CA3135464A1 (fr) Nouveau sel de cabozantinib
US20230093124A1 (en) Salts of Nintedanib and Crystalline Forms Thereof
CN110540539A (zh) 依鲁替尼的新晶型
AU2018203509A1 (en) Novel crystalline forms of Ibrutinib
CA3141320A1 (fr) Nouvelles formes cristallines d'apalutamide
WO2024000060A1 (fr) Sels de bélumosudil, formes cristallines et compositions pharmaceutiques de ceux-ci et leur utilisation dans le traitement d'une maladie chronique du greffon contre l'hôte
CA3006124A1 (fr) Nouvelles formes cristallines d'ibrutinib
EA020944B1 (ru) Кристаллическая форма i соли розувастатина цинка
CA3213159A1 (fr) Sels de viloxazine
SI21066A2 (sl) Amlodipin fumarat